Q3 FY2026 · ended Sep 27, 2026 · Revenue $1.13B, +4.2% YoY · Filed Oct 30, 2026
Illumina, Inc. (ILMN) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In Q3 of fiscal 2026, the quarter ended Sep 27, 2026, it reported revenue of $1.1 billion and net income of $220.0 million. Free cash flow was $379.0 million. As of Sep 27, 2026 it held $1.3 billion in cash and investments and $524.0 million in total debt.
Revenue
$1.13B
+4.2% vs year-ago quarter
Net income
$220.00M
+46.7% vs year-ago quarter
Operating cash flow
$419.00M
+47.5% vs year-ago quarter
Free cash flow
$379.00M
+49.8% vs year-ago quarter
EPS
$1.43
+45.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
151.20M
-1.0% vs year-ago quarter
Net cash
$813.00M
Q3 FY2026
Operating margin
21.2%
TTM
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- ILMN (Nasdaq)
- Fiscal year ends
- January 3
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1110803
- Former names
- ILLUMINA INC (until Aug 19, 2019)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 27, 2026 |
Q2 FY2026 Jun 28, 2026 |
Q1 FY2026 Mar 29, 2026 |
Q4 FY2025 Dec 28, 2025 |
Q3 FY2025 Sep 28, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.1B | $1.2B | $1.1B |
| Operating income | $305.0M | $245.0M | $209.0M | $201.0M | $227.0M |
| Net income | $220.0M | $207.0M | $134.0M | $334.0M | $150.0M |
| Diluted EPS | $1.43 | $1.35 | $0.87 | $2.18 | $0.98 |
| Operating cash flow | $419.0M | $201.0M | $289.0M | $321.0M | $284.0M |
| Free cash flow | $379.0M | $161.0M | $251.0M | $266.0M | $253.0M |
| Total assets | $6.8B | $6.7B | $6.6B | $6.6B | $6.2B |
| Stockholders' equity | $3.1B | $2.8B | $2.7B | $2.7B | $2.4B |
| Cash and investments | $1.3B | $1.2B | $1.2B | $1.6B | $1.3B |
| Total debt | $524.0M | $536.0M | $555.0M | $564.0M | $584.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 27, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Other events
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Aug 12, 2026 | Aug 10, 2026 |
All 1003 Illumina, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.